Caris Life Sciences, Inc. CAI

US Biotechnology

$25.30 ▼ -1.06% ($-0.27)

Open $26.11

Prev Close $25.57

Day Range $24.60 – $26.12

52W Range $14.19 – $36.50

Market Cap $7.33B

P/E (TTM) 68.82

Beta 0.49

EPS (TTM) $0.37

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2025-06-18
Shares Out.	282,600,000
Website	carislifesciences.com/ ↗
Phone	18667718946
Employees	1,846
Revenue	$275.4M
Gross Profit	$182.3M
Net Income	$15.3M
Free Cash Flow	$28.9M
Total Assets	$1.26B
Total Liabilities	$616.1M
Equity	$639.5M

About Caris Life Sciences, Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Caris Life Sciences, Inc. is a publicly traded company under the ticker symbol CAI on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.